microRNA-targeting antisense oligonucleotide therapy (Regulus Therapeutics)

N/A

Report date: 2025/03/20 15:23:30

NME

Base Information

Drug NamemicroRNA-targeting antisense oligonucleotide therapy (Regulus Therapeutics)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA

Mechanisms of ActionAntisense oligonucleotide inhibitors

TargetsUpdating

Therapy Area/IndicationsKidney Failure, ChronicRenal Insufficiency

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRegulus Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesRegulus Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsKidney Failure, ChronicRenal Insufficiency

Inactive IndicationsN/A

Other Information

ATC CodeN/A